drugset / Trial / NCT01185223
Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation
RandomizedParallel-groupOpen-labelPrevention
Summary
The objective of this study is to assess the efficacy and safety of oral valganciclovir versus intravenous ganciclovir in patients following allogenic stem cell transplantation.
Timeline
- Start
- 2010-09
- Primary completion
- 2012-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ganciclovir | Small molecule | 5 mg/kg | Intravenous |
| Subject | Valganciclovir | Small molecule | 450 mg | Oral |